News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs
Photo from Nieves Martinez Lago/X
Apr 14, 2024, 11:39

Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs

Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter:

“FDA approvals Tumor-Agnostic drugs:

  1. dMMR
  2. Pembrolizumab 2017
  3. Dostarlimab 2022
  4. MSI-H
  5. Pembrolizumab 2017
  6. TMB-High
  7. Pembrolizumab 2020
  8. NTRK fusions
  9. Larotrectinib 2018
  10. Entrectinib 2019
  11. BRAF V600E
  12. Dabrafenib + Trametinib 2022
  13. RET fusions
  14. Selpercatinib 2022
  15. HER2 3+
  16. T-derutxecan 2024.”

Source: Nieves Martinez Lago/X

BRAF V600E cancer dabrafenib dMMR Dostarlimab Drugs Entrectinib HER2 3+ larotrectinib MSI-H NTRK fusions OncoDaily Oncology pembrolizumab RET fusions Selpercatinib T-derutxecan TMB-High Trametinib Tumor-agnostic University Hospital Complex of Ferrol
Special Coverage
Opinion
Sep 16, 2024, 20:11
Zainab Shinkafi-Bagudu: Educating families about the early signs of childhood cancer
Blog
Sep 16, 2024, 19:54
Imagine a world where every child can dream big without the shadow of cancer - St. Baldrick’s Foundation
Insight
Sep 16, 2024, 19:51
Audrey Davis: We go far when go together
Insight
Sep 16, 2024, 19:46
Paolo Tarantino: A visit to the SOLTI headquarters at ESMO24
Blog
Sep 16, 2024, 19:38
Aakash Desai: Real-World Data on Immunotherapy Use in Early NSCLC
Blog
Sep 16, 2024, 19:34
Wafik S. El-Deiry: Busy month in Rhode Island
Blog
Sep 16, 2024, 19:29
Joshua Omale: Bridging the gap between awareness and action
Blog
Sep 16, 2024, 19:16
Gloria Chinyere Okwu: Excited to be speaking at the WCC 2024 on Incorporating Patient Voices into Care, Advocacy and Research
Blog
Sep 16, 2024, 18:23
Daniel Sumarriva: ESMO annual conference with our Caris Life Sciences team
Blog
Sep 16, 2024, 16:43
Princess Dina Mired: Our panel at World Cancer Congress 2024 on the plight of Gaza Cancer Patients
Societies
Sep 16, 2024, 16:31
40 Posts Not To Miss From ESMO24 Day 3
Societies
Sep 16, 2024, 16:18
Key Findings from the NIAGARA Trial at ESMO 2024